1. Home
  2. HIMX vs TARS Comparison

HIMX vs TARS Comparison

Compare HIMX & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HIMX
  • TARS
  • Stock Information
  • Founded
  • HIMX 2001
  • TARS 2016
  • Country
  • HIMX Taiwan
  • TARS United States
  • Employees
  • HIMX N/A
  • TARS N/A
  • Industry
  • HIMX Semiconductors
  • TARS Medicinal Chemicals and Botanical Products
  • Sector
  • HIMX Technology
  • TARS Health Care
  • Exchange
  • HIMX Nasdaq
  • TARS Nasdaq
  • Market Cap
  • HIMX 1.5B
  • TARS 1.7B
  • IPO Year
  • HIMX 2006
  • TARS 2020
  • Fundamental
  • Price
  • HIMX $9.38
  • TARS $73.55
  • Analyst Decision
  • HIMX Buy
  • TARS Strong Buy
  • Analyst Count
  • HIMX 1
  • TARS 7
  • Target Price
  • HIMX $15.00
  • TARS $67.14
  • AVG Volume (30 Days)
  • HIMX 1.1M
  • TARS 670.3K
  • Earning Date
  • HIMX 11-06-2025
  • TARS 11-12-2025
  • Dividend Yield
  • HIMX 4.07%
  • TARS N/A
  • EPS Growth
  • HIMX N/A
  • TARS N/A
  • EPS
  • HIMX 0.42
  • TARS N/A
  • Revenue
  • HIMX $889,561,000.00
  • TARS $295,521,000.00
  • Revenue This Year
  • HIMX N/A
  • TARS $137.28
  • Revenue Next Year
  • HIMX $16.64
  • TARS $42.84
  • P/E Ratio
  • HIMX $20.97
  • TARS N/A
  • Revenue Growth
  • HIMX N/A
  • TARS 254.45
  • 52 Week Low
  • HIMX $5.12
  • TARS $35.34
  • 52 Week High
  • HIMX $13.91
  • TARS $71.15
  • Technical
  • Relative Strength Index (RSI)
  • HIMX 60.43
  • TARS 77.43
  • Support Level
  • HIMX $8.16
  • TARS $66.79
  • Resistance Level
  • HIMX $9.22
  • TARS $71.15
  • Average True Range (ATR)
  • HIMX 0.37
  • TARS 2.95
  • MACD
  • HIMX 0.03
  • TARS 0.90
  • Stochastic Oscillator
  • HIMX 82.49
  • TARS 99.95

About HIMX Himax Technologies Inc.

Himax Technologies Inc is a semiconductor solution provider dedicated to display imaging processing technologies. It operates through the Driver Integrated Circuit and Non-Driver Products segments. The majority of the firm's revenue is derived from the Driver Integrated Circuit segment. It offers display driver ICs and timing controllers used in TVs, laptops, monitors, mobile phones, tablets, digital cameras, virtual reality (VR) devices, and many other consumer electronics devices. It also designs and provides controllers for touch sensor displays, in-cell Touch and Display Driver Integration single-chip solutions, LED driver ICs, power management ICs, and scaler products for monitors and projectors. Geographically, it generates the majority of its revenue from China.

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

Share on Social Networks: